Bottom line
What is CXRN's expense ratio?
CXRN's expense ratio is 0.95%, or about $95 a year on every $10,000 invested. That is cheaper than 82% of leveraged & inverse funds we track (median 1.31%).
Updated Apr 29, 2026
CXRN fee table
| Net expense ratio | 0.95% |
|---|---|
| Gross expense ratio | 1.49% |
| Management fee | 1.49% |
| 12b-1 (distribution) fee | 0% |
| Other expenses | 0% |
| Fee waiver / reimbursement | -0.54% |
| Max front-end sales load | None (ETF) |
Source: Fund prospectus fee table, filed Apr 29, 2026
What CXRN costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| CXRN | $97 | $418 | $762 | $1,733 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 0.95% expense ratio costs roughly $52,800 in lost growth, versus about $70,600 for the median leveraged & inverse fund (1.31%).